STOCK TITAN

Medtronic Plc - MDT STOCK NEWS

Welcome to our dedicated news page for Medtronic Plc (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medtronic Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medtronic Plc's position in the market.

Rhea-AI Summary
Medtronic files a complaint with the U.S. International Trade Commission and U.S. District Court against Axonics for patent infringement related to MRI compatibility of medical devices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
The press release highlights the success of the MAPS program in removing barriers to education, with Candi Sneed being the first link in a chain of future engineers. The program's impact on education and diversity is emphasized, showcasing a positive step towards empowering underrepresented groups in engineering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
-
Rhea-AI Summary
Medtronic plc (MDT) reports strong Q3 FY24 results with revenue of $8.1 billion, up 4.7%, and raises full-year guidance. Key highlights include growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and Diabetes. The company received FDA approvals for innovative products and provided updates on its Cardiovascular, Neuroscience, Medical Surgical, and Diabetes portfolios.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
earnings
Rhea-AI Summary
Medtronic's Chief Inclusion and Diversity Officer emphasizes the importance of healing in a corporate context, focusing on addressing workplace exclusion, intolerance, toxicity, and discrimination. The company is committed to fostering a more inclusive and equitable workplace, despite facing challenges such as DEI backlash and extreme polarization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
-
Rhea-AI Summary
Medtronic highlights its commitment to inclusion, diversity, and equity (ID&E) in its Annual Report, focusing on efforts to build and maintain an inclusive culture, representation goals, and sharing actionable progress with data and real employee stories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
none
-
Rhea-AI Summary
Medtronic plc (NYSE:MDT) will report financial results for its third quarter of fiscal year 2024 on February 20, 2024. The news release will include summary financial information for the company's third quarter, which ended on January 26, 2024. A video webcast will be hosted to discuss the results, with a replay and transcript available within 24 hours. Additionally, plans for reporting fiscal year 2024 fourth quarter results and fiscal year 2025 quarterly results were outlined.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
earnings
Rhea-AI Summary
JUST Capital, in collaboration with CNBC, released its annual JUST 100 list, recognizing American corporate leadership on business issues prioritized by the public. Medtronic was named one of America's Most JUST Companies for the 2nd consecutive year, demonstrating commitment to serving workers, customers, communities, the environment, and shareholders. The JUST 100 companies outperform their peers financially and demonstrate better performance in areas such as paying a living wage, career development training, parental leave, water usage, CO2 emissions, renewable energy use, profit margin, return on equity, and dividend yield.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
-
Rhea-AI Summary
Medtronic has been investing in renewable energy sources like solar, with a commitment to be net zero by 2045. The company's first solar farm opened in 2014 and they have since expanded their solar energy footprint globally, with the recent addition of a solar energy farm at their Mounds View, Minnesota campus. Medtronic used approximately 414,300 megawatt hours (MWh) of renewable electricity last year, accounting for more than 46% of their total electricity usage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
-
Rhea-AI Summary
Medtronic LABS president, Ruchika Singhal, was named the 2024 'Corporate Social Innovator of the Year' by the Schwab Foundation for Social Entrepreneurship. The independent nonprofit organization, supported by Medtronic, has impacted over 1.6 million patients, enrolled 237,000 people in healthcare programs, and improved over 100,000 lives through its data, technology, and partnerships to address health issues in underserved communities globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
Rhea-AI Summary
Medtronic plc (MDT) announces FDA approval of Percept™ RC Deep Brain Stimulation (DBS) system, the latest innovation in the Percept™ family, offering personalized treatment for patients with movement disorders and epilepsy. The system features BrainSense™ technology, SenSight™ directional leads, and a rechargeable neurostimulator with at least 15 years of service life and rapid recharging capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags
fda approval
Medtronic Plc

NYSE:MDT

MDT Rankings

MDT Stock Data

111.16B
1.33B
0.11%
85.14%
0.74%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Minneapolis

About MDT

Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.